For example, a number of different (including pharmacological, genetic and enzyme replacement) approaches have been investigated for XLMTM due to X-linked recessive mutations in myotubularin, a regulator of the PtdIns3P pool essential for phagophore formation in the early stages of autophagy [217,218]. The gene discussed is MTM1; the disease is X-linked myotubular myopathy.